Principal Financial Group Inc. Acquires 15,235 Shares of Integer Holdings Corporation $ITGR

Principal Financial Group Inc. grew its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 7.4% in the first quarter, Holdings Channel reports. The institutional investor owned 221,000 shares of the medical equipment provider’s stock after acquiring an additional 15,235 shares during the period. Principal Financial Group Inc.’s holdings in Integer were worth $19,448,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Heartland Advisors Inc. lifted its position in Integer by 506.8% in the 4th quarter. Heartland Advisors Inc. now owns 242,715 shares of the medical equipment provider’s stock valued at $19,036,000 after acquiring an additional 202,715 shares in the last quarter. WINTON GROUP Ltd bought a new stake in Integer during the 4th quarter worth approximately $4,836,000. Jennison Associates LLC bought a new stake in Integer during the 4th quarter worth approximately $1,036,000. Kestrel Investment Management Corp purchased a new stake in shares of Integer in the fourth quarter worth approximately $5,933,000. Finally, William Blair Investment Management LLC raised its stake in shares of Integer by 70.1% in the fourth quarter. William Blair Investment Management LLC now owns 468,377 shares of the medical equipment provider’s stock worth $36,735,000 after purchasing an additional 192,956 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ITGR has been the topic of several analyst reports. Truist Financial lifted their target price on Integer from $97.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, July 16th. KeyCorp reissued an “overweight” rating and issued a $104.00 price target on shares of Integer in a research report on Tuesday. Piper Sandler restated an “overweight” rating and set a $97.00 price objective (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Zacks Research cut Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a report on Thursday, June 18th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $97.00.

Integer Trading Down 0.0%

NYSE:ITGR opened at $96.05 on Wednesday. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $116.31. The firm has a 50-day moving average price of $91.97 and a two-hundred day moving average price of $87.81. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75. The firm has a market cap of $3.26 billion, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 2.29 and a beta of 0.64.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.Integer’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. On average, equities analysts expect that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.